List of insiders holdings for Blueprint Medicines Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | LEVIN MARK J 10% Owner | 2017-03-20 16:21:02 | 111,244 3,453,753 | 3,564,997 | Form 4 |
2 | FMR LLC See Remark 1 | 2025-02-12 09:16:22 | 2,247,679 0 | 2,247,679 | Form 13G |
3 | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner | 2019-02-13 16:04:32 | 1,022,165 0 | 1,022,165 | Form 13G |
4 | Kuvalanka Kyle D. Chief Business Officer | 2015-04-30 07:17:30 | 187,271 0 | 187,271 | Form 3 |
5 | Haviland Kate CHIEF EXECUTIVE OFFICER | 2025-04-03 16:30:32 | 165,929 0 | 165,929 | Form 4 |
6 | Albers Jeffrey W. Director | 2025-03-17 16:26:03 | 146,630 0 | 146,630 | Form 4 |
7 | LYNCH DANIEL Director | 2020-06-26 16:08:05 | 132,404 0 | 132,404 | Form 4 |
8 | Borisy Alexis Director | 2024-06-14 17:32:54 | 78,730 0 | 78,730 | Form 4 |
9 | Namouni Fouad PRESIDENT, R & D | 2025-03-07 16:13:30 | 75,781 0 | 75,781 | Form 4 |
10 | Landsittel Michael CHIEF FINANCIAL OFFICER | 2025-03-07 16:10:50 | 72,924 0 | 72,924 | Form 4 |
11 | Rossi Christina CHIEF OPERATING OFFICER | 2025-03-26 16:27:48 | 69,266 0 | 69,266 | Form 4 |
12 | McCain Tracey L EVP AND CHIEF LEGAL OFFICER | 2025-03-07 16:12:36 | 66,583 0 | 66,583 | Form 4 |
13 | Lydon Nicholas Director | 2024-06-14 17:34:57 | 62,596 0 | 62,596 | Form 4 |
14 | Carter Percy H. CHIEF SCIENTIFIC OFFICER | 2025-03-07 16:06:35 | 56,865 0 | 56,865 | Form 4 |
15 | Lengauer Christoph Chief Scientific Officer | 2016-04-14 17:55:33 | 56,657 0 | 56,657 | Form 4 |
16 | Dorsch Marion Chief Scientific Officer | 2021-02-24 16:28:01 | 55,672 0 | 55,672 | Form 4 |
17 | Durso-Bumpus Debra CHIEF PEOPLE OFFICER | 2025-03-07 16:07:54 | 49,606 0 | 49,606 | Form 4 |
18 | Lee Philina CHIEF COMMERCIAL OFFICER | 2025-03-07 16:11:40 | 41,996 0 | 41,996 | Form 4 |
19 | Boral Anthony L. Chief Medical Officer | 2020-12-16 16:03:37 | 35,630 0 | 35,630 | Form 4 |
20 | Murray Christopher K. CHIEF TECHNICAL OPERATIONS | 2024-03-11 18:24:10 | 33,853 0 | 33,853 | Form 4 |
21 | Hewes L. Becker CHIEF MEDICAL OFFICER | 2025-03-07 16:15:08 | 30,419 0 | 30,419 | Form 4 |
22 | Goldberg Mark Alan Director | 2024-06-14 17:34:16 | 22,824 0 | 22,824 | Form 4 |
23 | Seely Lynn Director | 2024-06-14 17:35:43 | 17,824 0 | 17,824 | Form 4 |
24 | Hurley Ariel PRINCIPAL ACCOUNTING OFFICER | 2025-03-07 16:09:49 | 16,944 0 | 16,944 | Form 4 |
25 | Beckman Daniella Director | 2024-06-14 17:38:40 | 15,412 0 | 15,412 | Form 4 |
26 | Demetri George Director | 2022-06-30 21:53:27 | 13,712 0 | 13,712 | Form 4 |
27 | Tsai John Director | 2024-06-14 17:36:27 | 13,312 0 | 13,312 | Form 4 |
28 | Dable Habib J Director | 2024-06-14 17:32:07 | 13,312 0 | 13,312 | Form 4 |
29 | Tango Therapeutics Inc. Director | 2021-12-10 16:25:29 | 10,400 0 | 10,400 | Form 4 |
30 | Rowland Charles A Jr Director | 2021-06-04 16:16:55 | 10,312 0 | 10,312 | Form 4 |
31 | COATS LONNEL Director | 2024-11-22 16:47:52 | 5,430 0 | 5,430 | Form 4 |